Mar 3, 2020 | New Therapies & Programs
Presented on October 3, 2018 Richard L. Hengel, MD Timothy E. Ritter, MD Ramesh V. Nathan, MD, FIDSA Lucinda J. Van Anglen, PharmD Stephen W. Marcella Kevin W. Garey, Pharm.D., M.S., FASHP View Poster 
Mar 3, 2020 | New Therapies & Programs
Presented on November 26, 2018 Authors: Quyen Luu, MD – Central Georgia Infectious Diseases Associates, Macon, GA Barry Statner, MD, FRCPC, FIDSA – Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA Robin H. Dretler, MD – Infectious Disease...Oct 2, 2019 | New Therapies & Programs
Kevin W. Garey – University of Houston College of Pharmacy, Houston, TX Claudia P. Schroeder – Healix Infusion Therapy, Sugar Land, TX Thomas C. Hardin – Healix Infusion Therapy, Sugar Land, TX Richard L. Hengel – Atlanta ID Group, Atlanta, GA...May 18, 2019 | New Therapies & Programs
Authors: Timothy E. Ritter, MD – Texas Digestive Disease Consultants, Southlake, TX, U.S. Harry E. Sarles, MD – DHAT Research Institute, Garland, TX, U.S. Robert C. McLeay, PhD – DoseMeRx, Brisbane, Australia Lucinda J. Van Anglen, PharmD – Healix LLC, Sugar Land, TX,...Feb 22, 2019 | New Therapies & Programs
Authors: Richard F. Herrscher, MD, FACAAI – AIRCare, Dallas, Texas Tidence L. Prince, MD – The Allergy Asthma and Sinus Center, Knoxville, TN Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Sugar Land, TX Claudia P. Schroeder, PharmD, PhD... 
Oct 3, 2018 | New Therapies & Programs
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Sugar Land, TX Thomas C. Hardin, PharmD – Healix Infusion Therapy, Sugar Land, TX Claudia P. Schroeder, PharmD, PhD – Healix Infusion Therapy, Sugar Land, TX View...
Recent Comments